Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Salou Diallo
Observed names:
Diallo Salou,
Diallo, Salou
Institutions:
Centre National de la Recherche Scientifique et Technologique,
Institut de Recherche en Sciences de la Santé,
Clinical Research Unit Nanoro
Observed institutions:
Centre National de la Recherche Scientifique et Technologique,
Institut de Recherche en Sciences de la Santé,
Clinical Research Unit Nanoro
ORCID:
0000-0002-1253-4726
Observed ORCID:
0000-0002-1253-4726
OpenAlex ID:
A5129174650
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
2024
·
Mehreen S Datoo
, Alassane Dicko
, et al.
·
The Lancet
·
453
PDF
Update on malaria vaccine deployment and challenges in the field
2026
·
H. Magloire Natama
, Toussaint Rouamba
, et al.
·
Clinical Microbiology and Infection
MOESM2 of Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries
2017
·
Drakeley, Chris
, Abdulla, Salim
, et al.
·
Figshare
MOESM3 of Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries
2017
·
Drakeley, Chris
, Abdulla, Salim
, et al.
·
Figshare
MOESM1 of Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries
2017
·
Drakeley, Chris
, Abdulla, Salim
, et al.
·
Figshare
Show more works
View as search
Works count:
27
Citation count:
453
H-index:
1
I10-index:
1
Year
Topic
Type